Aug 09, 2024 / 08:30AM GMT
Operator
Ladies and gentlemen, good day, and welcome to J. B. Pharma's Q1 FY25 Earnings Conference Call as on the 9 of August 2024. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. Jason DâSouza, Executive Vice President at J. B. Pharma. Thank you, and over to you, sir.
Jason Dsouza - J B Chemicals and Pharmaceuticals Ltd - Vice President - Investor Relations
Thank you, Rio. Welcome to the earnings call of J. B. Pharma. We have with us today, Nikhil Chopra, CEO and Whole-Time Director; Kunal Khanna, President, Operations; and Narayan Saraf, CFO at J. B. Chemicals & Pharmaceuticals Limited.
Before we begin, I would like to state that some of the statements in today's discussion may be forward-looking in nature and may involve certain risks and uncertainties. A detailed statement in this regard is available in the Q1 FY25 results presentation that has been sent to you earlier. I would like to hand over the floor to Mr. Nikhil Chopra to begin the proceedings of the call for his opening remarks.
Q1 2025 J B Chemicals and Pharmaceuticals Ltd Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot